Cytosorbents Corp
CTSO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001175151
In the last 90 days, Cytosorbents Corp insiders filed 4 open-market purchases and 0 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $6.04M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Cytosorbents Corp changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 54 | 50 | −4 |
| Shares | 18.1M | 17.6M | −479.9K (−2.7%) |
| Value | $20.0M | $16.7M | −$3.35M (−16.7%) |
New holders (2)
Institutions that held Cytosorbents Corp at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 46,655 | $44.3K | 0.00% |
| Susquehanna International Group, LLP | 16,198 | $15.4K | 0.00% |
Sold out (6)
Institutions that held Cytosorbents Corp at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Ledgewood Wealth Advisors, LLC | 73,000 | $81.0K |
| Dimensional Fund Advisors LP | 56,570 | $62.7K |
| Virtu Financial LLC | 20,215 | $22.0K |
| Charles Schwab Investment Management Inc | 15,994 | $17.8K |
| US Bancorp | 10,000 | $11.1K |
| Advisory Services Network, LLC | 2,200 | $2.44K |